Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation

Insulin and insulin growth factor type 1 (IGF-1) and their receptors are closely related molecules, but both factors bind to the receptor of the other one with a weak affinity. No study has presently documented a role of insulin as a myeloma growth factor (MGF) for human multiple myeloma cells (MMCs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sprynski, A. C. (VerfasserIn) , Hose, Dirk (VerfasserIn) , Kassambara, A. (VerfasserIn) , Vincent, L. (VerfasserIn) , Jourdan, M. (VerfasserIn) , Rossi, J. F. (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Klein, B. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 16 September 2010
In: Leukemia
Year: 2010, Jahrgang: 24, Heft: 11, Pages: 1940-1950
ISSN:1476-5551
DOI:10.1038/leu.2010.192
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/leu.2010.192
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/leu2010192
Volltext
Verfasserangaben:A.C. Sprynski, D. Hose, A. Kassambara, L. Vincent, M. Jourdan, J.F. Rossi, H. Goldschmidt and B. Klein

MARC

LEADER 00000caa a2200000 c 4500
001 1860822584
003 DE-627
005 20240311123514.0
007 cr uuu---uuuuu
008 231005s2010 xx |||||o 00| ||eng c
024 7 |a 10.1038/leu.2010.192  |2 doi 
035 |a (DE-627)1860822584 
035 |a (DE-599)KXP1860822584 
035 |a (OCoLC)1425873516 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sprynski, A. C.  |e VerfasserIn  |0 (DE-588)130501278X  |0 (DE-627)1860821987  |4 aut 
245 1 0 |a Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation  |c A.C. Sprynski, D. Hose, A. Kassambara, L. Vincent, M. Jourdan, J.F. Rossi, H. Goldschmidt and B. Klein 
264 1 |c 16 September 2010 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.10.2023 
520 |a Insulin and insulin growth factor type 1 (IGF-1) and their receptors are closely related molecules, but both factors bind to the receptor of the other one with a weak affinity. No study has presently documented a role of insulin as a myeloma growth factor (MGF) for human multiple myeloma cells (MMCs), whereas many studies have concluded that IGF-1 is a major MGF. IGF-1 receptor (IGF-1R) is aberrantly expressed by MMCs in association with a poor prognosis. In this study we show that insulin receptor (INSR) is increased throughout normal plasma cell differentiation. INSR gene is also expressed by MMCs of 203/206 newly diagnosed patients. Insulin is an MGF as potent as IGF-1 at physiological concentrations and requires the presence of insulin/IGF-1 hybrid receptors, stimulating INSR+IGF-1R+ MMCs, unlike INSR+IGF-1R− or INSR−IGF-1R− MMCs. Immunoprecipitation experiments indicate that INSR is linked with IGF-1R in MMCs and that insulin induces both IGF-1R and INSR phosphorylations and vice versa. In conclusion, we demonstrate for the first time that insulin is an MGF as potent as IGF-1 at physiological concentrations and its activity necessitates insulin/IGF-1 hybrid receptor activation. Further therapeutic strategies targeting the IGF/IGF-1R pathway have to take into account neutralizing the IGF-1R-mediated insulin MGF activity. 
650 4 |a Insulin signalling 
650 4 |a Myeloma 
700 1 |a Hose, Dirk  |d 1969-  |e VerfasserIn  |0 (DE-588)139824995  |0 (DE-627)613790308  |0 (DE-576)313431698  |4 aut 
700 1 |a Kassambara, A.  |e VerfasserIn  |4 aut 
700 1 |a Vincent, L.  |e VerfasserIn  |4 aut 
700 1 |a Jourdan, M.  |e VerfasserIn  |4 aut 
700 1 |a Rossi, J. F.  |e VerfasserIn  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Klein, B.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 24(2010), 11, Seite 1940-1950  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation 
773 1 8 |g volume:24  |g year:2010  |g number:11  |g pages:1940-1950  |g extent:11  |a Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation 
856 4 0 |u https://doi.org/10.1038/leu.2010.192  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/leu2010192  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20231005 
993 |a Article 
994 |a 2010 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |d 50000  |e 910000PG102258023X  |e 910100PG102258023X  |e 50000PG102258023X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 7 
998 |g 139824995  |a Hose, Dirk  |m 139824995:Hose, Dirk  |d 910000  |d 910100  |e 910000PH139824995  |e 910100PH139824995  |k 0/910000/  |k 1/910000/910100/  |p 2 
999 |a KXP-PPN1860822584  |e 4381663039 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1860822584","title":[{"title":"Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation","title_sort":"Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation"}],"physDesc":[{"extent":"11 S."}],"origin":[{"dateIssuedDisp":"16 September 2010","dateIssuedKey":"2010"}],"name":{"displayForm":["A.C. Sprynski, D. Hose, A. Kassambara, L. Vincent, M. Jourdan, J.F. Rossi, H. Goldschmidt and B. Klein"]},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"disp":"Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activationLeukemia","part":{"issue":"11","year":"2010","text":"24(2010), 11, Seite 1940-1950","volume":"24","pages":"1940-1950","extent":"11"},"id":{"eki":["32046699X"],"issn":["1476-5551"],"zdb":["2008023-2"]},"note":["Gesehen am 15.03.04"],"origin":[{"dateIssuedKey":"1997","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedDisp":"1997-","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}],"pubHistory":["Nachgewiesen 11.1997 -"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"32046699X","title":[{"subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia","title_sort":"Leukemia"}]}],"note":["Gesehen am 05.10.2023"],"id":{"doi":["10.1038/leu.2010.192"],"eki":["1860822584"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Sprynski, A. C.","role":"aut","given":"A. C.","family":"Sprynski"},{"display":"Hose, Dirk","role":"aut","given":"Dirk","family":"Hose"},{"family":"Kassambara","given":"A.","display":"Kassambara, A.","role":"aut"},{"role":"aut","display":"Vincent, L.","family":"Vincent","given":"L."},{"display":"Jourdan, M.","role":"aut","family":"Jourdan","given":"M."},{"display":"Rossi, J. F.","role":"aut","given":"J. F.","family":"Rossi"},{"display":"Goldschmidt, Hartmut","role":"aut","family":"Goldschmidt","given":"Hartmut"},{"family":"Klein","given":"B.","role":"aut","display":"Klein, B."}]} 
SRT |a SPRYNSKIACINSULINISA1620